International Journal of Science, Engineering and TechnologyAuthors: Selva Kumar, Prakash Nayak, Srinivas.S
Abstract: Nanobiotechnology represents a groundbreaking convergence of nanotechnology and biotechnology, offering transformative potential for the healthcare sector. This interdisciplinary field harnesses the unique properties of nanoscale materials and biological systems to develop innovative solutions that vastly improve diagnostic accuracy, therapeutic delivery, and tissue regeneration. Recent advancements include the creation of highly sensitive nanosensors capable of detecting diseases at their earliest stages, targeted drug delivery systems that minimize side effects by precisely directing medication to affected cells, and bioengineered nanomaterials that promote tissue repair and regeneration. Healthcare enterprises adopting these cutting-edge technologies can significantly enhance patient outcomes by enabling earlier diagnosis, more effective treatments, and faster recovery times. This article delves into emerging trends such as the fusion of nanobiotechnology with artificial intelligence (AI) to enable predictive diagnostics and precision medicine, as well as the emphasis on sustainable nanomaterial development to reduce environmental impact. It also discusses the importance of establishing robust partnerships among academia, industry, and regulators to accelerate innovation while ensuring safety and ethical standards. By providing a comprehensive overview of technological advancements, practical applications, and strategic considerations, this study equips healthcare enterprises with the knowledge needed to navigate the evolving landscape of nanobiotechnology. Ultimately, the integration of nanobiotechnology into healthcare promises to usher in a new era of personalized, efficient, and intelligent medical care that will redefine the future of health services worldwide.
DOI: http://doi.org/10.61463/ijset.vol.12.issue6.979
